Peter Lang Selected Research

Peter Lang Research Topics

Disease

27	Neoplasms (Cancer) 10/2022 - 01/2004
22	Leukemia 06/2021 - 02/2003
20	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 02/2003
18	Infections 01/2022 - 12/2003
15	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 12/2003
9	Neuroblastoma 10/2022 - 05/2006
7	Residual Neoplasm 11/2022 - 09/2010
6	Adenoviridae Infections (Adenovirus Infections) 08/2021 - 02/2005
6	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2014 - 11/2004
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2022 - 12/2003
5	COVID-19 01/2022 - 11/2020
5	Viremia 08/2015 - 11/2010
5	Lymphoma (Lymphomas) 11/2014 - 11/2004
4	Disease Progression 10/2020 - 07/2009
4	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2018 - 04/2006
3	Virus Diseases (Viral Diseases) 01/2022 - 07/2006
3	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021 - 01/2018
3	Vomiting 04/2020 - 01/2019
3	Mycoses (Diseases, Fungus) 08/2015 - 07/2012
3	Inflammation (Inflammations) 10/2014 - 03/2010
2	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 01/2022 - 09/2020
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022 - 10/2020
2	Acute Promyelocytic Leukemia 08/2021 - 05/2011
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2021 - 10/2019
2	Hemorrhage 10/2020 - 07/2007
2	Nausea 04/2020 - 01/2019
2	Hemoglobinopathies 01/2019 - 01/2018
2	Osteonecrosis (Kienbock's Disease) 10/2018 - 08/2012
2	Cytopenia 01/2018 - 03/2005
2	Body Weight (Weight, Body) 01/2017 - 10/2012
2	Bacteremia 01/2016 - 08/2015
2	Sepsis (Septicemia) 01/2016 - 08/2015
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2014 - 07/2009
2	Autoimmune Diseases (Autoimmune Disease) 08/2012 - 04/2004
2	Pulmonary Aspergillosis 08/2012 - 01/2012
2	Ewing Sarcoma (Sarcoma, Ewing) 09/2011 - 01/2005
2	Juvenile Myelomonocytic Leukemia 09/2011 - 02/2003
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2008 - 04/2004
2	Arteriovenous Malformations (Arteriovenous Malformation) 11/2005 - 11/2005
2	Heterotaxy Syndrome 11/2005 - 11/2005
2	Lymphopenia (Lymphocytopenia) 03/2005 - 03/2004
1	Alveolar Rhabdomyosarcoma 01/2022
1	Pheochromocytoma 01/2022
1	Thrombotic Microangiopathies 01/2022
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022

Drug/Important Bio-Agent (IBA)

8	Antiviral Agents (Antivirals)IBA 01/2022 - 03/2004
5	AntigensIBA 01/2021 - 04/2004
5	SteroidsIBA 01/2021 - 03/2010
4	CytokinesIBA 01/2022 - 01/2004
4	Proteins (Proteins, Gene)FDA Link 07/2012 - 05/2008
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2014
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 10/2014
3	Peptides (Polypeptides)IBA 01/2022 - 11/2008
3	blinatumomabIBA 06/2021 - 07/2014
3	KIR ReceptorsIBA 01/2015 - 04/2004
3	LigandsIBA 01/2015 - 01/2004
2	Anaplastic Lymphoma KinaseIBA 10/2022 - 01/2018
2	dinutuximabIBA 01/2022 - 01/2021
2	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 01/2019
2	Arsenic Trioxide (Trisenox)FDA Link 08/2021 - 05/2011
2	AntibodiesIBA 06/2021 - 01/2013
2	Monoclonal AntibodiesIBA 04/2021 - 01/2014
2	Interleukin-2 (IL2)IBA 01/2021 - 09/2011
2	Chimeric Antigen ReceptorsIBA 01/2021 - 01/2020
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 12/2019
2	fosaprepitant FDA Link 01/2020 - 01/2019
2	AntiemeticsIBA 01/2020 - 01/2019
2	Biological ProductsIBA 11/2019 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2013
2	posaconazole FDA Link 07/2017 - 10/2012
2	Immunoglobulins (Immunoglobulin)IBA 12/2014 - 07/2014
2	liposomal amphotericin B FDA Link 07/2012 - 01/2012
2	Single-Chain AntibodiesIBA 11/2008 - 07/2005
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2007 - 05/2006
1	Bispecific AntibodiesIBA 11/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2022
1	Cerebroside-Sulfatase (Arylsulfatase A)IBA 01/2022
1	Insulin-Like PeptidesIBA 01/2022
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022
1	GangliosidesIBA 01/2022
1	EnzymesIBA 01/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2021
1	Plasminogen Activator Inhibitor 1IBA 11/2021
1	Acyclovir (Aciclovir)FDA LinkGeneric 08/2021
1	brincidofovirIBA 08/2021

Therapy/Procedure

35	Stem Cell Transplantation 01/2021 - 12/2003
33	Therapeutics 10/2022 - 12/2003
24	Hematopoietic Stem Cell Transplantation 01/2022 - 02/2007
23	Transplantation 01/2022 - 02/2003
14	Immunotherapy 11/2022 - 05/2004
9	Drug Therapy (Chemotherapy) 01/2021 - 07/2009
4	Haploidentical Transplantation 10/2014 - 09/2004
2	Homologous Transplantation 11/2022 - 04/2015
2	Aftercare (After-Treatment) 01/2016 - 11/2014
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2015 - 01/2004
2	Right Heart Bypass (Cavopulmonary Anastomosis) 11/2005 - 11/2005
1	Chemoradiotherapy 01/2022
1	Radioimmunotherapy 01/2022
1	Contraindications 08/2021